Effect of monocrotophos, an organophosphorus insecticide, on the striatal dopaminergic system in a mouse model of Parkinson's disease

被引:10
|
作者
Ali, Shaheen Jafri [1 ]
Rajini, Padmanabhan Sharda [1 ]
机构
[1] Cent Food Technol Res Inst, CSIR, Dept Food Protectants & Infestat Control, Mysore 570020, Karnataka, India
关键词
Dopamine; mice; monocrotophos; oxidative stress; Parkinson's disease; striatum; tyrosine hydroxylase; ACUTE CHLORPYRIFOS EXPOSURE; INDUCED OXIDATIVE STRESS; ALPHA-SYNUCLEIN; TIME-COURSE; VITAMIN-C; PESTICIDES; ACETYLCHOLINESTERASE; MPTP; DAMAGE; BRAIN;
D O I
10.1177/0748233714547733
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Our earlier study had shown that low concentrations of monocrotophos (MCP) elicited dopaminergic features of Parkinson's disease (PD) in the nematode Caenorhabditis elegans. In the present study, the effect of low doses of MCP on the striatal dopaminergic neurons was investigated using the mouse model system. MCP was initially screened for its ability to cause any neurobehavioral deficits and alterations in the dopaminergic system in Swiss albino mice, aged 8 weeks and weighing 25-30 g, with repeated doses at 0.3 and 0.6 mg/kg body weight (b.w.)/day for 7 days and 30 days. Mice were treated with four intraperitoneal injections for every 2 h with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) at the dosage of 14 mg/kg b.w. MCP was administered to these mice at the above-mentioned doses for 7 days. Mice administered with MCP alone revealed a significant < 0.05) reduction in the dopamine (DA) content at both 7 and 30 days and showed a significant (p < 0.05) increase in neurobehavioral deficits. Interestingly, when MCP was administered for 7 days to MPTP-treated mice, further significant decrease in both DA content and increase in neurobehavioral deficits were apparent. The extent of reactive oxygen species and lipid peroxidation were markedly increased, while the ratio of reduced to oxidized glutathione levels were significantly decreased (p < 0.05) in the treated mice as compared to the control. Significant histopathological alterations and a marked reduction in the number of tyrosine hydroxylase positive cells were evident in striatum of mice treated with higher doses of MCP. These changes were comparable to that seen in mice treated with MPTP and post-administered lower doses of MCP. Our findings suggest that MCP per se has the propensity to induce pathological changes in the dopaminergic neurons as well as augment the degeneration in a compromised nigrostriatal system such as that in PD.
引用
收藏
页码:1153 / 1165
页数:13
相关论文
共 50 条
  • [21] The Effect of Forced Exercise on Striatal and Serum Serotonin Levels in a Parkinson's Mouse Model
    Dogru, Nadide Ozkul
    Yigit, Hatica Kubra
    Yildirim, Aysegul Burcin
    Ulusal, Hasan
    Orkmez, Mustafa
    Yigit, Elif
    Celik, Hakim
    EUROPEAN JOURNAL OF THERAPEUTICS, 2023, 29 (02): : 179 - 187
  • [22] Demethylenetetrahydroberberine protects dopaminergic neurons in a mouse model of Parkinson's disease
    Wen Jing
    Zhang Yuan-Qiang
    Liu Dong-Qing
    Yao Xu-Tao
    Jiang Hua
    Zhang Yu-Bin
    CHINESE JOURNAL OF NATURAL MEDICINES, 2022, 20 (02) : 111 - 119
  • [23] Effect of tomato intake on striatal monoamine level in a mouse model of experimental Parkinson's disease
    Suganuma, H
    Hirano, T
    Arimoto, Y
    Inakuma, T
    JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2002, 48 (03) : 251 - 254
  • [24] Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease
    Carlsson, Thomas
    Schindler, Friederike R.
    Hoellerhage, Matthias
    Depboylu, Candan
    Arias-Carrion, Oscar
    Schnurrbusch, Stefan
    Roesler, Thomas W.
    Wozny, Wojciech
    Schwall, Gerhard P.
    Groebe, Karlfried
    Oertel, Wolfgang H.
    Brundin, Patrik
    Schrattenholz, Andre
    Hoeglinger, Guenter U.
    JOURNAL OF NEUROCHEMISTRY, 2011, 117 (06) : 1066 - 1074
  • [25] Initial Molecular Mechanisms of the Pathogenesis of Parkinson's Disease in a Mouse Neurotoxic Model of the Earliest Preclinical Stage of This Disease
    Kolacheva, Anna
    Pavlova, Ekaterina
    Bannikova, Alyona
    Bogdanov, Vsevolod
    Ugrumov, Michael
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (02)
  • [26] The effect of truncated human α-synuclein (1-120) on dopaminergic cells in a transgenic mouse model of Parkinson's Disease
    Michell, A. W.
    Tofaris, G. K.
    Gossage, H.
    Tyers, P.
    Spillantini, M. G.
    Barker, R. A.
    CELL TRANSPLANTATION, 2007, 16 (05) : 461 - 474
  • [27] Development of Midbrain Dopaminergic Neurons and the Advantage of Using hiPSCs as a Model System to Study Parkinson's Disease
    Samson, Jennifer Sally
    Ramesh, Anuradha
    Parvathi, Venkatachalam Deepa
    NEUROSCIENCE, 2024, 546 : 1 - 19
  • [28] Focused Ultrasound Promotes the Delivery of Gastrodin and Enhances the Protective Effect on Dopaminergic Neurons in a Mouse Model of Parkinson's Disease
    Wang, Yuhong
    Luo, Kaixuan
    Li, Junrui
    Liao, Yehui
    Liao, Chengde
    Chen, Wen-Shiang
    Chen, Moxian
    Ao, Lijuan
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2022, 16
  • [29] Changes in the Content of Sphingolipids in the Nigrostriatal Dopaminergic System in the Brain of Mice with a Neurotoxic Model of Parkinson's Disease
    Alessenko, A., V
    Blokhin, V. E.
    Shupik, M. A.
    Gutner, U. A.
    Lebedev, A. T.
    Maloshitskaya, O. A.
    Sokolov, S. A.
    Ugrumov, M., V
    NEUROCHEMICAL JOURNAL, 2021, 15 (02) : 175 - 180
  • [30] PRDX6 Exacerbates Dopaminergic Neurodegeneration in a MPTP Mouse Model of Parkinson's Disease
    Yun, Hyung-Mun
    Choi, Dong Young
    Oh, Ki Wan
    Hong, Jin Tae
    MOLECULAR NEUROBIOLOGY, 2015, 52 (01) : 422 - 431